Single-arm study | Inaxaplin reduces proteinuria in patients with APOL1 variants and focal segmental glomerulosclerosis
21 Mar, 2023 | 13:11h | UTCInaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Inaxaplin Reduces Proteinuria in FSGS With APOL1 Variants – Renal & Urology News
Commentary on Twitter
Original Article: Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants https://t.co/QHcvbYEmiz #nephrology #CKD pic.twitter.com/SLspl6Vagn
— NEJM (@NEJM) March 17, 2023